Heyoka955/rteee huggingface dataset:
30 sep 25   corero network sec. - further re directorate change corero network security plc | cns | 11.5 0.50 4.5% | mkt cap: 58.9m    rns number : 2896b corero network security plc 30 september 2025   30 september 2025     corero network security plc ("corero" or the "company")   further re directorate change   corero (aim: cns) (otcqx: ddosf), the distributed denial of service ("ddos") protection specialists, announces that further to the announcement dated 16 september 2025, ashley stephenson, chief technology officer, has today stepped down from the company's board. as per the 16 september 2025 announcement, ashley will remain in his role as chief technology officer until 31st december 2025, at which time he will retire from the company.   jens montanana, chairman at corero, commented:   "ashley has been instrumental in developing corero's industry leading ddos protection solutions during his twelve years at the company. on behalf of myself and the board i wish ashley the very best in his future beyond corero."   enquiries:   corero network security plc tel: +44(0)20 7390 0230 carl herberger, chief executive officer  chris goulden, chief financial officer      canaccord genuity limited (nominated adviser and joint broker) tel: +44(0)20 7523 8000 simon bridges / andrew potts / harry rees   zeus capital (joint broker) ben robertson / ed bellows     tel: +44(0)20 3829 5000   vigo consulting (financial pr and investor relations) tel: +44(0)20 7390 0230 jeremy garcia / anna sutton  corero@vigoconsulting.com    harbor access (investor relations) jonathan paterson tel: +1 475 477 9401     about corero network security   corero network security is a leading provider of ddos protection solutions, delivering real-time, automated detection and mitigation with deep network visibility and analytics. corero safeguards critical infrastructure across diverse deployment models-from inline to edge to hybrid cloud-through its smartwallonetm solution and core, an observability and resiliency ecosystem to unify defensive actions across the modern threat landscape. with operational centres in marlborough, massachusetts, usa, and edinburgh, uk, corero is listed on the london stock exchange's aim market (ticker: cns) and the us otcqx market (otcqx: ddosf).   for more information, visit www.corero.com, and follow us on linkedin and x. this information is provided by rns, the news service of the london stock exchange. rns is approved by the financial conduct authority to act as a primary information provider in the united kingdom. terms and conditions relating to the use and distribution of this information may apply. for further information, please contact rns@lseg.com or visit www.rns.com.  rns may use your ip address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. for further information about how rns and the london stock exchange use the personal data you provide us, please see our privacy policy.   end   boappubwbupagqb return to news summary

Label: Gestiegen
30 sep 25   banco santander s.a. - total voting rights banco santander, s.a. | bnc | 770 9.0 1.2% | mkt cap: 114,691m    rns number : 4411b banco santander s.a. 30 september 2025    banco santander, s.a. ("the company") total voting rights in accordance with the financial conduct authority's (fca) disclosure guidance and transparency rule 5.6.1r, the company notifies the market that as at 30 september 2025: 1.   the company's issued share capital comprised 14,885,325,372 ordinary shares of eur 0.50 each, each with one vote. ordinary shares of eur 0.50 each held in treasury amounted to 69,887,884   2.   therefore, for the purpose of the fca's disclosure guidance and transparency rule 5.6.1r, the total number of voting rights in the company was 14,815,437,488 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the company under the fca's disclosure guidance and transparency rules.   enquiries:     gema navamuel santander investor relations investor@gruposantander.com     lei: 5493006qmfddmywiam13   end     this information is provided by rns, the news service of the london stock exchange. rns is approved by the financial conduct authority to act as a primary information provider in the united kingdom. terms and conditions relating to the use and distribution of this information may apply. for further information, please contact rns@lseg.com or visit www.rns.com.  rns may use your ip address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. for further information about how rns and the london stock exchange use the personal data you provide us, please see our privacy policy.   end   tvreaenedslsefa return to news summary

Label: Gesunken
30 sep 25   intertek group plc - total voting rights intertek group plc | itrk | 4,666 14.0 0.3% | mkt cap: 7,205m    rns number : 4321b intertek group plc 30 september 2025   30 september 2025     intertek group plc   total voting rights and capital   in accordance with the requirements of disclosure guidance and transparency rule 5.6.1, intertek group plc announces that it has 154,406,321 ordinary 1p shares admitted to trading, all of which have voting rights.                                                                            this figure may be used by shareholders as the denominator for their calculations to determine whether they are required to notify their interest in, or a change in their interest in, intertek group plc under the fca's disclosure guidance and transparency rules.                               the company does not hold any shares in treasury.   contact:   ida woodger (group company secretary) +44 (0) 20 7396 3400    this information is provided by rns, the news service of the london stock exchange. rns is approved by the financial conduct authority to act as a primary information provider in the united kingdom. terms and conditions relating to the use and distribution of this information may apply. for further information, please contact rns@lseg.com or visit www.rns.com.  rns may use your ip address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. for further information about how rns and the london stock exchange use the personal data you provide us, please see our privacy policy.   end   tvrzzgflggvgkzm return to news summary

Label: Neutral
30 sep 25   srt marine systems - issue of equity srt marine systems plc | srt | 90.5 -0.50 (-0.5%) | mkt cap: 227.4m    rns number : 4167b srt marine systems plc 30 september 2025   srt marine systems plc (aim: srt) ("srt" or the "company")   issue of equity the directors of srt announce that they have issued and allotted 375,000 new ordinary shares of 0.1p each in the company ("ordinary shares") following the conversion of employee share options in the company at an exercise price of 0.1p per ordinary share.   application has been made for the 375,000 new ordinary shares to be admitted to trading on aim which is expected to occur on 3 october 2025 ("admission").   following admission, the company will have 215,590,656 ordinary shares of 0.1p in issue with each share carrying the right to one vote. this is the total voting rights figure which may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in the company under the financial conduct authority's disclosure guidance and transparency rules.  for further information, please contact: srt marine systems plc www.srt-marine.com  + 44 (0) 1761 409500 simon tucker (ceo) simon.tucker@srt-marine.com kevin finn (chairman) kevin.finn@srt-marine.com   cavendish capital markets limited (nomad & broker) jonny franklin-adams / teddy whiley / finn gordon (corporate finance) +44 (0) 20 7220 0500 tim redfern (corporate broking)  yellow jersey pr charles goodwin / annabelle wills +44 (0)774 7788 221 srt@yellowjerseypr.com     about srt marine systems plc: srt marine systems plc is an established leader in the growing global market for maritime domain awareness. we provide technology driven solutions for coastal and eez surveillance, fisheries management and monitoring and navigation safety and efficiency. our customers range from government agencies such as coast guards, fishery authorities and ports & waterway authorities to commercial and leisure vessel owners.  this information is provided by rns, the news service of the london stock exchange. rns is approved by the financial conduct authority to act as a primary information provider in the united kingdom. terms and conditions relating to the use and distribution of this information may apply. for further information, please contact rns@lseg.com or visit www.rns.com.  rns may use your ip address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. for further information about how rns and the london stock exchange use the personal data you provide us, please see our privacy policy.   end   ioesdmsaseiselu return to news summary

Label: Gesunken
30 sep 25   hemogenyx pharma plc - total voting rights hemogenyx pharmaceuticals plc | hemo | 1,148 -12.5 (-1.1%) | mkt cap: 61.5m    rns number : 8369a hemogenyx pharmaceuticals plc 30 september 2025   30 september 2025   hemogenyx pharmaceuticals plc  ("hemogenyx pharmaceuticals" or the "company")   total voting rights   hemogenyx pharmaceuticals plc (lse: hemo), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces that the total issued share capital of the company as at 30 september 2025 consists of 5,361,267 ordinary shares of 1p each, none of which are held in treasury. therefore, the total number of voting rights in the company is 5,361,267. the figure of 5,361,267 ordinary shares may be used by shareholders of the company as the denominator for the calculations by which they will determine if they are required to notify their investment in, or a change in their interest in, the share capital of the company under the financial conduct authority's disclosure guidance and transparency rules.     enquiries: hemogenyx pharmaceuticals plc https://hemogenyx.com dr vladislav sandler, chief executive officer & co-founder headquarters@hemogenyx.com peter redmond, director peter.redmond@hemogenyx.com sp angel corporate finance llp tel: +44 (0)20 3470 0470 matthew johnson, vadim alexandre, adam cowl  peterhouse capital limited tel: +44 (0)20 7469 0930 lucy williams, duncan vasey, charles goodfellow    about hemogenyx pharmaceuticals plc hemogenyx pharmaceuticals is a publicly traded company (lse: hemo) headquartered in london, with its us operating subsidiaries, hemogenyx pharmaceuticals llc and immugenyx llc, located in new york city.   the company is a clinical stage biopharmaceutical group developing new medicines and treatments to treat blood and autoimmune diseases. hemogenyx pharmaceuticals is developing several distinct and complementary product candidates, as well as platform technologies that it uses as engines for novel product development.   this information is provided by rns, the news service of the london stock exchange. rns is approved by the financial conduct authority to act as a primary information provider in the united kingdom. terms and conditions relating to the use and distribution of this information may apply. for further information, please contact rns@lseg.com or visit www.rns.com.  rns may use your ip address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. for further information about how rns and the london stock exchange use the personal data you provide us, please see our privacy policy.   end   tvreannsadpseea return to news summary

Label: Gestiegen
30 sep 25   crest nicholson hdgs - total voting rights crest nicholson holdings plc | crst | 163 2.8 1.7% | mkt cap: 418.1m    rns number : 4435b crest nicholson holdings plc 30 september 2025       crest nicholson holdings plc (the 'company')   total voting rights   in accordance with the fca's disclosure guidance and transparency rules (the rules) the company announces that as at 30 september 2025 the company's issued share capital is 256,930,563 ordinary shares of 5p each (shares). the shares carry voting rights of one vote per share. the company does not hold any shares in treasury.   the above figure of 256,930,563 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the company's shares under the rules.         for further information, please contact:   penny thomas group company secretary +44(0)7977 851249   30 september 2025 this information is provided by rns, the news service of the london stock exchange. rns is approved by the financial conduct authority to act as a primary information provider in the united kingdom. terms and conditions relating to the use and distribution of this information may apply. for further information, please contact rns@lseg.com or visit www.rns.com.  rns may use your ip address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. for further information about how rns and the london stock exchange use the personal data you provide us, please see our privacy policy.   end   tvreafnedeksefa return to news summary

Label: Gestiegen
30 sep 25   experian plc - total voting rights experian plc | expn | 3,704 -1.0 (0.0%) | mkt cap: 33,991m    rns number : 4365b experian plc 30 september 2025   experian plc     total voting rights     30 september 2025 - experian plc, the global data and technology company (the "company"), hereby notifies the market, in conformity with the fca's disclosure guidance and transparency rule 5.6.1r, of the following:     as at 30 september 2025, the company's capital consists of 973,709,622 ordinary shares of 10 us cents each with voting rights and 20 deferred shares of 10 us cents each which have no voting rights. experian plc holds 56,150,170 shares in treasury. therefore, the total number of voting rights in experian plc is 917,559,452.   the figure of 917,559,452 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the company's shares under the fca's disclosure guidance and transparency rules.                                                                                                                     contact:   experian claire murphy                            deputy company secretary                   +353 (0) 87 118 4397     about experian   experian is a global data and technology company, powering opportunities for people and businesses around the world. we help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. we also assist millions of people to realise their financial goals and help them to save time and money.   we operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.   we invest in talented people and new advanced technologies to unlock the power of data and innovate. as a ftse 100 index company listed on the london stock exchange (expn), we have a team of 25,200 people across 32 countries. our corporate headquarters are in dublin, ireland. learn more at experianplc.com.   this information is provided by rns, the news service of the london stock exchange. rns is approved by the financial conduct authority to act as a primary information provider in the united kingdom. terms and conditions relating to the use and distribution of this information may apply. for further information, please contact rns@lseg.com or visit www.rns.com.  rns may use your ip address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. for further information about how rns and the london stock exchange use the personal data you provide us, please see our privacy policy.   end   tvrursrrvrukoar return to news summary

Label: Neutral
30 sep 25   contango holdingsplc - annual financial report contango holdings plc | cgo | 0.8 -0.10 (-10.8%) | mkt cap: 6.25m    rns number : 3831b contango holdings plc 30 september 2025   contango holdings plc   ("contango" or the "company")   audited final results for the year ended 31 may 2025 contango holdings plc, a company focused on unlocking value from the +2 billion tonne muchesu coal project in zimbabwe ("muchesu"), is pleased to announce the publication of its audited results for the year ended 31 may 2025 ("fy 2025"). a copy of the full report and accounts can be found on the company's website at www.contango-holdings-plc.co.uk and will shortly be filed on the national storage mechanism ("nsm").   **ends**   for further information, please visit www.contango-holdings-plc.co.uk or contact:   contango holdings plc   chief executive officer   danny dos santos     tavira financial limited   financial adviser & broker   jonathan evans     t: +44 (0)20 7100 5100   st brides partners ltd   financial pr & investor relations   susie geliher / zoe briggs   t: +44 (0)20 7236 1177     this information is provided by rns, the news service of the london stock exchange. rns is approved by the financial conduct authority to act as a primary information provider in the united kingdom. terms and conditions relating to the use and distribution of this information may apply. for further information, please contact rns@lseg.com or visit www.rns.com.  rns may use your ip address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. for further information about how rns and the london stock exchange use the personal data you provide us, please see our privacy policy.   end   acssdismseisefu return to news summary

Label: Gesunken
30 sep 25   amigo holdings plc - amigo holdings plc: liquidation of subsidiaries amigo holdings plc | amgo | 0.3 0 0.0% | mkt cap: 1.85m    rns number : 2963b amigo holdings plc 30 september 2025   for immediate release 30 september 2025   amigo holdings plc ("amigo" "plc" or the "company") update   as previously announced on 17 september 2025, all of amigo's subsidiaries have today appointed chris laverty and sean croston of grant thornton uk advisory & tax llp (the "liquidators") as joint liquidators to carry out (solvent) members' voluntary liquidations of the company's subsidiaries ("subsidiaries"). before this process began, the subsidiaries transferred all available cash amounting to approximately £740,000 ("surplus"), to amigo. in return, amigo has agreed to indemnify the liquidators and the subsidiaries against all costs and expenses associated with winding up the affairs of the subsidiaries and dissolving these entities by way of solvent liquidations. these costs and expenses are expected to total around £290,000, leaving amigo with approximately £450,000 ("funds"). the funds will be used to cover amigo's minimal ongoing operating expenses and support its continued efforts to identify a suitable reverse takeover target. importantly, the funds arose as the costs of making and administering a further scheme payment (to the approximately 135,000 scheme creditors under the redress scheme) was more than the funds available for distribution, as referenced in the scheme supervisors' final progress report which was posted on 29 august 2025.   amigo holdings plc investors@amigo.me nick beal chief executive      sponsor beaumont cornish 0207 628 3396   this announcement contains inside information for the purposes of regulation 11 of the market abuse (amendment) (eu exit) regulations 2019/310 (as amended). the person responsible for this announcement is nicholas beal, company secretary.  about amigo holdings plc amigo is a public limited company registered in england and wales with registered number 10024479. the amigo shares are listed on the official list of the london stock exchange. -ends- this information is provided by rns, the news service of the london stock exchange. rns is approved by the financial conduct authority to act as a primary information provider in the united kingdom. terms and conditions relating to the use and distribution of this information may apply. for further information, please contact rns@lseg.com or visit www.rns.com.  rns may use your ip address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. for further information about how rns and the london stock exchange use the personal data you provide us, please see our privacy policy.   end   updbrgdcsdddguc return to news summary

Label: Gestiegen